ClinicalTrials.gg
RecruitingNCT06745180HABITSUpdated Oct 1, 2025

Making Healthy Habits Stick

An interventional study of Short Message System (SMS) and Peer Coach in Cancer, Physical Activity and Cancer Survivor, sponsored by University of Tennessee. Recruiting at 2 sites in United States. Open to female participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2025-10-01.

Sponsored by University of Tennessee · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
260
Allocation
Randomized
Ages
19 Years and older
Sex
Female
01

Study summary

The aim of this project is to help increase physical activity maintenance in cancer survivors.

Read the detailed description

The purpose of the study is to evaluate novel interventions designed to assist women cancer survivors, who identify as African American or Black, in overcoming exercise barriers, developing a physically active mindset, and establishing exercise habits needed to exercise long term. These novel interventions are 1. Text Messaging (SMS), 2. Peer Coaching, 3. Combination of Peer Coaching and SMS, 4. Usual Care

02

Conditions studied

  • Cancer
  • Physical Activity
  • Cancer Survivor
  • Cancer Survivorship

Keywords

  • Physical Activity
  • Cancer
  • Cancer Survivor
  • Exercise
  • Cancer Survivorship
03

In context

Neoplasms

10,838 studies on the registry are indexed under Neoplasms; 2,322 are open to participants now.

This study's planned enrollment of 260 is above the median of 60 across 7,716 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

University of Tennessee is the lead sponsor of 142 studies on the registry; 21 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 2 (29%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • woman age of 19 or older
  • identifies as African American or Black
  • have a history of cancer
  • have completed post-primary treatment for cancer (i.e., chemotherapy, radiation)
  • agree to allow research team to confirm cancer diagnosis with your physician
  • If received surgery, must be at least 8 weeks post-surgery
  • willing to have regular physician provide medical clearance for study participation
  • willing to provide home address if qualified for the study
  • willing and able to use videoconference platform such as Zoom for study activities (must be both willing and able)
  • willing and able to send and/or receive text messages (must be both willing and able)
  • has US phone number
  • has an email address
  • if has no email address, must be willing to create one
  • English speaking
  • Able to ambulate without assistance (does not need to use a cane, a walker, or a wheelchair)
  • willing and able to complete 3-5 exercise session per week on their own for the duration of the study; if answered no, please explain
  • willing to attend individual and group sessions via videoconferences during study participation; if answered no, please explain.
  • willing to attend assessments via videoconference during study participation; if answered no, please explain.
  • willing to complete surveys during study participation; if answered no, please explain.

Exclusion criteria

Exclusion Criteria:

  • or recurrent cancer
  • another cancer diagnosis in the past 5 years (not including skin or cervical cancer in situ)
  • have severe orthopedic, joints or any other condition that stops individual from being active
  • unstable angina
  • have paint, tightness, or heaviness in chest EITHER when resting OR then physically active
  • have class II, III, OR IV congestive heart failure
  • blood pressure has been over 160/100 at least twice in the past 6 months (either number; 160 or 100)
  • have uncontrolled asthma
  • have interstitial lung disease that requires extra oxygen
  • have dementia or organize brain syndrome
  • have schizophrenia or active psychosis
  • have had a stroke or other problem that left individual disables or with paralysis (unable to move or feel any part of body)
  • have hearing problems that make it hard to carry on a phone conversation
  • blind or partially blind
  • planned surgery during the first 6 month of study participation (if unapproved by PI)
  • planned knee or hip surgery during the first 6 month of study participation
  • anticipate changes in usual medications during the first 6 months of study participation (if unapproved by PI)
  • have been told by a physician to only do exercise prescribed by a physician
  • have been told by a physician to limit physical activity
  • have a to engaging in moderate intensity aerobic exercise
  • have completed on average, more than 90 min/week of moderate-intensity or more that 30 min/week of vigorous exercise in the past 6 months
  • trouble with balance or moving around safely
  • are currently pregnant or anticipate pregnant during study participation
  • currently participating in another exercise study
  • have ≥ 50
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
260 participants (estimated)

Study arms

  • Experimental
    Peer Coach and SMS

    SMS and peer coach interventions focused on physical activity maintenance

    Behavioral: Peer Coach and SMS

  • Experimental
    Peer Coach

    Peer coach intervention focused on physical activity maintenance

    Behavioral: Peer Coach

  • Experimental
    Short Message Service (SMS)

    SMS intervention focused on physical activity maintenance

    Behavioral: Short Message System (SMS)

  • Other
    Usual Care

    Written materials focused on physical activity maintenance

    Behavioral: Usual Care

Interventions

  • BehavioralShort Message System (SMS)

    The Short Message System (SMS) intervention focuses on personalized, adaptive SMS messages that help the participant maintain physical activity behaviors.

    Also known as: SMS, Short Message Service

  • BehavioralPeer Coach

    The peer coach will deliver an intervention that will help participants maintain physical activity.

    Also known as: Peer Support, Peer Sustainability

  • BehavioralUsual Care

    Participants will be given written materials providing advice on maintaining their physical activity.

  • BehavioralPeer Coach and SMS

    The Short Message System (SMS) intervention focuses on personalized, adaptive SMS messages that help the participant maintain physical activity behaviors. The peer coach will deliver an intervention that will help participants maintain physical activity.

06

What researchers measure

Primary outcomes

  1. Physical Activity (patient reported outcome)

    Participants will wear motion sensor on waist for 7 days

    Time frame: From Baseline to 15 Month Assessment

Secondary outcomes

  1. Fatigue (Patient reported outcome)

    Fatigue will be measured using the Fatigue Symptom Inventory (fatigue intensity and interference) scale.

    Time frame: At Baseline, 3 month assessment, 9 month assessment, and 15 month assessment.

  2. Self-perceived Health (Patient reported outcome)

    Self-perceived health will be measured using the EQ-5D questionnaire.

    Time frame: At Baseline, 3 month assessment, 9 month assessment, and 15 month assessment.

  3. Qualify of life (Patient reported outcome)

    Quality of life will be measured via the PROMIS Global Health questionnaire.

    Time frame: At Baseline, 3 month assessment, 9 month assessment, and 15 month assessment.

  4. Anxiety & Depression (patient reported outcome)

    Anxiety and depression will be measured using the Hospital Anxiety and Depression Scale.

    Time frame: At Baseline, 3 month assessment, 9 month assessment, and 15 month assessment.

Other outcomes

  1. Stress (patient reported outcome)

    Stress will be measured using the Perceived Stress Scale

    Time frame: At Baseline, 3 months, 9 months, and 15 months

  2. Social Determinants of Health

    Social determinants of health will be measured using the Social Determinants of Health (SDoH) questionnaire.

    Time frame: At Baseline, 3 months, 9 months, 15 months

  3. Big Five Personality (patient reported outcome)

    Big five personality will be measured using a brief version of the Big Five Personality Inventory questionnaire.

    Time frame: At Baseline, 3 months, 9 months, 15 months

  4. Self-report Physical Activity

    Aerobic and resistance exercise will be measured using the Godin Aerobic Strength questionnaire.

    Time frame: At Baseline, 3 months, 9 months, 15 months

  5. Quality of Life (patient reported outcome)

    Quality of life will be measured using the EQ-5D-5L questionnaire.

    Time frame: At Baseline, 3 months, 9 months, 15 months

  6. Social Support for Physical Activity (patient reported outcome)

    Social support for physical activity will be measured using the Social Support for PA questionnaire.

    Time frame: At Baseline, 3 months, 9 months, 15 months

  7. Reflective, Regulatory, and Reflexive processes (patient reported outcome)

    Reflective, regulatory, and reflexive processes is being measured by the M-PAC physical activity questionnaire.

    Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 15 months

  8. Perceived Exercise Barriers Interference

    Barriers to exercise will be measured using the Perceived Barriers to Exercise questionnaire.

    Time frame: At Baseline, 3 months, 9 months, 15 months

07

Study locations

2 of 2 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — Individuals interested in requesting IPD should contact the study PIs.

Supporting information: Informed consent form

Time frame: After data management is finalized (and data locked) and the manuscript reporting physical activity maintenance data at month 15 has been submitted

Access criteria: A data use agreement between the institution housing the data (UTHSC) and the institution of the requesting researcher will be required.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Mar 2028, 38 months after the start.

Of 1,993 non-industry interventional studies with no phase under Neoplasms, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 52. This study's planned 38 months is above that.

Counting every sponsor, half of 2,068 studies reached it within 29 months; a quarter within 13 and three quarters within 52.

Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 17, 2024
First posted
Dec 20, 2024
StartActual
Jan 27, 2025
Primary completionEst.
Mar 31, 2028
CompletionEst.
Mar 31, 2028
Last update
Oct 1, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06745180
Responsible party
Sponsor
First posted
Dec 20, 2024
Start date
Jan 27, 2025
Primary completion
Mar 31, 2028 (estimated)
Completion
Mar 31, 2028 (estimated)
Last update
Oct 1, 2025

Study contacts

Michelle Martin, PhD
Contact
mmart126@uthsc.edu
901-448-2383
Talia Williams, BA
Contact
twill213@uthsc.edu
901-448-8682
Michelle Martin, PhD
principal investigator · University of Tennessee
Laura Rogers, MD, MPH
principal investigator · University of Alabama at Birmingham

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion